Selective and efficient inhibition of the alternative pathway of complement by a mAb that recognizes C3b/iC3b
- 1 March 2006
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 43 (7) , 1010-1019
- https://doi.org/10.1016/j.molimm.2005.05.003
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in miceMolecular Immunology, 2005
- The complement system in regulation of adaptive immunityNature Immunology, 2004
- The alternative pathway of complement in disease: opportunities for therapeutic targetingMolecular Immunology, 2004
- Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassaysMolecular Immunology, 2004
- An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximabBlood, 2003
- ComplementNew England Journal of Medicine, 2001
- Linkages of innate and adaptive immunityCurrent Opinion in Immunology, 1998
- Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor BBiochemistry, 1992
- MOLECULAR ORGANIZATION AND FUNCTION OF THE COMPLEMENT SYSTEMAnnual Review of Biochemistry, 1988
- Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.The Journal of Experimental Medicine, 1981